Literature DB >> 18208480

Serotonergic signalling in the stomach and duodenum of patients with gastroparesis.

N van Lelyveld1, J Ter Linde, M Schipper, M Samsom.   

Abstract

Serotonin (5-HT) is involved in the regulation of motoric and sensory functions of the upper gastrointestinal tract. The aim of the current study was to determine whether serotonergic signalling is altered in patients with idiopathic gastroparesis. Mucosal biopsy specimens were collected from the duodenum, antrum and fundus of 11 patients with idiopathic gastroparesis and 11 healthy controls. Neuroendocrine cells, specifically 5-HT producing cells, were counted after immunohistochemistry, and non-neuronal mRNA expression levels of tryptophan hydroxylase (TPH)-1, 5-HT transport protein (SERT), 5-HT3 and 5-HT4 receptor were quantified by real time RT-PCR. The number of 5-HT producing cells was comparable between patients and controls. No difference in expression of TPH-1 (rate limiting enzyme in 5-HT biosynthetic pathway) and SERT (responsible for 5-HT uptake) was found between patients and controls (P > 0.05). In the duodenum, the expression of the 5-HT3 receptor subunits and the 5-HT4 receptor was comparable between both groups. However, the 5-HT4(c) splice variant was expressed more abundantly in healthy controls compared to patients (P = 0.015). This study suggests that the delayed gastric emptying and upper abdominal symptoms in idiopathic gastroparesis do not result from altered mucosal 5-HT biosynthetic and uptake capacity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18208480     DOI: 10.1111/j.1365-2982.2007.01068.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  6 in total

1.  Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients.

Authors:  Christophe Faure; Natalie Patey; Cindy Gauthier; Elice M Brooks; Gary M Mawe
Journal:  Gastroenterology       Date:  2010-03-17       Impact factor: 22.682

2.  Serotonin and the GI tract.

Authors:  William L Hasler
Journal:  Curr Gastroenterol Rep       Date:  2009-10

Review 3.  Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders.

Authors:  J Tack; M Camilleri; L Chang; W D Chey; J J Galligan; B E Lacy; S Müller-Lissner; E M M Quigley; J Schuurkes; J H De Maeyer; V Stanghellini
Journal:  Aliment Pharmacol Ther       Date:  2012-02-22       Impact factor: 8.171

4.  Gastric Serotonin Biosynthesis and Its Functional Role in L-Arginine-Induced Gastric Proton Secretion.

Authors:  Ann-Katrin Holik; Kerstin Schweiger; Verena Stoeger; Barbara Lieder; Angelika Reiner; Muhammet Zopun; Julia K Hoi; Nicole Kretschy; Mark M Somoza; Stephan Kriwanek; Marc Pignitter; Veronika Somoza
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

5.  Novel Primate Model of Serotonin Transporter Genetic Polymorphisms Associated with Gene Expression, Anxiety and Sensitivity to Antidepressants.

Authors:  Andrea M Santangelo; Mitsuteru Ito; Yoshiro Shiba; Hannah F Clarke; Evelien Hs Schut; Gemma Cockcroft; Anne C Ferguson-Smith; Angela C Roberts
Journal:  Neuropsychopharmacology       Date:  2016-03-21       Impact factor: 7.853

Review 6.  A link between gastrointestinal disorders and migraine: Insights into the gut-brain connection.

Authors:  Sheena K Aurora; Stephen B Shrewsbury; Sutapa Ray; Nada Hindiyeh; Linda Nguyen
Journal:  Headache       Date:  2021-04-01       Impact factor: 5.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.